Female-led stocks: Who rules the world?
35 No. of Symbols
Next report date
Report period
Q1 2024
EPS estimate
0.42CHF
Revenue estimate
8.07 BCHF
1.304CHF
5.28 BCHF
32.51 BCHF
3.73 B
About GSK PLC ORD GBP0.3125
Sector
CEO
Emma N. Walmsley
Headquarters
Middlesex
Website
Employees (FY)
70.21 K
FIGI
BBG007FJNLV0
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where GS71 is featured.
Frequently Asked Questions
The current price of GS71 is 18.595 CHF — it has increased by 1.65% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange GSK PLC stocks are traded under the ticker GS71.
GSK PLC is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
GS71 stock is 1.62% volatile and has beta coefficient of 0.52. Check out the list of the most volatile stocks — is GSK PLC there?
GS71 earnings for the last quarter are 0.56 CHF per share, whereas the estimation was 0.51 CHF resulting in a 10.63% surprise. The estimated earnings for the next quarter are 0.31 CHF per share. See more details about GSK PLC earnings.
GSK PLC revenue for the last quarter amounts to 9.10 B CHF despite the estimated figure of 8.60 B CHF. In the next quarter revenue is expected to reach 8.17 B CHF.
Yes, you can track GSK PLC financials in yearly and quarterly reports right on TradingView.
GS71 stock has risen by 1.10% compared to the previous week, the month change is a 3.74% fall, over the last year GSK PLC has showed a 9.70% increase.
GS71 net income for the last quarter is 375.12 M CHF, while the quarter before that showed 1.63 B CHF of net income which accounts for −77.05% change. Track more GSK PLC financial stats to get the full picture.
Today GSK PLC has the market capitalization of 76.64 B, it has increased by 1.07% over the last week.
GSK PLC dividend yield was 4.00% in 2023, and payout ratio reached 47.69%. The year before the numbers were 4.26% and 16.49% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, GS71 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GSK PLC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 70.21 K employees. See our rating of the largest employees — is GSK PLC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GSK PLC technincal analysis shows the neutral today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GSK PLC stock shows the neutral signal. See more of GSK PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GSK PLC future price: according to them, GS71 price has a max estimate of 28.75 CHF and a min estimate of 13.53 CHF. Read a more detailed GSK PLC forecast: see what analysts think of GSK PLC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GSK PLC EBITDA is 10.51 B CHF, and current EBITDA margin is 30.62%. See more stats in GSK PLC financial statements.